-- Martine A Rothblatt, Director, Chairperson & CEO, on April 17, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,573,223. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,797 common shares of the company, with 40,513 shares held directly and 639,284 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1082554/000110657826000035/xslF345X05/primarydocument.xml
SK hynix (KRX:000660) plans to build P&T7, an advanced packaging fab in the Technopolis Industrial Complex in Cheongju to meet global demand for AI memory, the South Korean semiconductor firm said in a Wednesday filing with the Korea Exchange.The company will invest about 19 trillion won for factory construction and production facility setup, the filing said.
Paladin Energy (PDN.TO) on Wednesday reported a year-over-year increase in fiscal third-quarter uranium production, citing strong processing plant performance.From the Langer Heinrich Mine in Namibia, the company produced 1.29 million pounds of U3O8, up from 745,484 pounds in the year-ago quarter.Sales of U3O8 came in at 1.03 Mlb, up from 872,435 lb. Average realized price was US$68.3/lb, down from $69.9/lb.The company increased its production guidance range for fiscal 2026 to a range of 4.5 Mlb and 4.8 Mlb of U3O8, citing strong year-to-date performance.Paladin had cash and investments of $219.5 million and an undrawn revolving credit facility of $70 million as of quarter-end.